Asia-Pacific Parkinson's Disease Drug Market Report 2018

January 2018 | 112 pages | ID: ACDE78B5666EN
QYResearch

Abstracts

In this report, the Asia-Pacific Parkinson's Disease Drug market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Parkinson's Disease Drug for these regions, from 2012 to 2022 (forecast), including

• China
• Japan
• South Korea
• Taiwan
• India
• Southeast Asia
• Australia

Asia-Pacific Parkinson's Disease Drug market competition by top manufacturers/players, with Parkinson's Disease Drug sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck
• Akorn
• GSK
• Novartis
• Boehringer Ingelheim
• Teva Pharmaceutical
• Abbvie
• Kyowa Hakko Kirin Pharma
• Astellas Pharma
• Desitin Arzneimittel
• Endo Pharmaceuticals
• F.Hoffmann-La Roche
• H.Lundbeck
• Valeant
• Apokyn
• Orion
• Stada Arzneimittel
• US WorldMeds
• Valeant Pharmaceuticals

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into

• Sinemet-CR
• Trastal
• Madopar
• COMT Inhibitor
• Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Under 40 Years Old
• 40-65 Years Old
• Above 65 Years Old

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Asia-Pacific Parkinson's Disease Drug Market Report 2017

1 PARKINSON'S DISEASE DRUG OVERVIEW

1.1 Product Overview and Scope of Parkinson's Disease Drug
1.2 Classification of Parkinson's Disease Drug by Product Category
  1.2.1 Asia-Pacific Parkinson's Disease Drug Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Parkinson's Disease Drug Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Sinemet-CR
  1.2.4 Trastal
  1.2.5 Madopar
  1.2.6 COMT Inhibitor
  1.2.7 Other
1.3 Asia-Pacific Parkinson's Disease Drug Market by Application/End Users
  1.3.1 Asia-Pacific Parkinson's Disease Drug Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Under 40 Years Old
  1.3.3 40-65 Years Old
  1.3.4 Above 65 Years Old
1.4 Asia-Pacific Parkinson's Disease Drug Market by Region
  1.4.1 Asia-Pacific Parkinson's Disease Drug Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Parkinson's Disease Drug (2012-2022)
  1.5.1 Asia-Pacific Parkinson's Disease Drug Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Parkinson's Disease Drug Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC PARKINSON'S DISEASE DRUG COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Parkinson's Disease Drug Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Parkinson's Disease Drug Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Parkinson's Disease Drug Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Parkinson's Disease Drug (Volume and Value) by Type
  2.2.1 Asia-Pacific Parkinson's Disease Drug Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Parkinson's Disease Drug Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Parkinson's Disease Drug (Volume) by Application
2.4 Asia-Pacific Parkinson's Disease Drug (Volume and Value) by Region
  2.4.1 Asia-Pacific Parkinson's Disease Drug Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Parkinson's Disease Drug Revenue and Market Share by Region (2012-2017)

3 CHINA PARKINSON'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 China Parkinson's Disease Drug Sales and Value (2012-2017)
  3.1.1 China Parkinson's Disease Drug Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
  3.1.3 China Parkinson's Disease Drug Sales Price Trend (2012-2017)
3.2 China Parkinson's Disease Drug Sales Volume and Market Share by Type
3.3 China Parkinson's Disease Drug Sales Volume and Market Share by Application

4 JAPAN PARKINSON'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Parkinson's Disease Drug Sales and Value (2012-2017)
  4.1.1 Japan Parkinson's Disease Drug Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Parkinson's Disease Drug Sales Price Trend (2012-2017)
4.2 Japan Parkinson's Disease Drug Sales Volume and Market Share by Type
4.3 Japan Parkinson's Disease Drug Sales Volume and Market Share by Application

5 SOUTH KOREA PARKINSON'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Parkinson's Disease Drug Sales and Value (2012-2017)
  5.1.1 South Korea Parkinson's Disease Drug Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Parkinson's Disease Drug Sales Price Trend (2012-2017)
5.2 South Korea Parkinson's Disease Drug Sales Volume and Market Share by Type
5.3 South Korea Parkinson's Disease Drug Sales Volume and Market Share by Application

6 TAIWAN PARKINSON'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Parkinson's Disease Drug Sales and Value (2012-2017)
  6.1.1 Taiwan Parkinson's Disease Drug Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Parkinson's Disease Drug Sales Price Trend (2012-2017)
6.2 Taiwan Parkinson's Disease Drug Sales Volume and Market Share by Type
6.3 Taiwan Parkinson's Disease Drug Sales Volume and Market Share by Application

7 INDIA PARKINSON'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 India Parkinson's Disease Drug Sales and Value (2012-2017)
  7.1.1 India Parkinson's Disease Drug Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
  7.1.3 India Parkinson's Disease Drug Sales Price Trend (2012-2017)
7.2 India Parkinson's Disease Drug Sales Volume and Market Share by Type
7.3 India Parkinson's Disease Drug Sales Volume and Market Share by Application

8 SOUTHEAST ASIA PARKINSON'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Parkinson's Disease Drug Sales and Value (2012-2017)
  8.1.1 Southeast Asia Parkinson's Disease Drug Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Parkinson's Disease Drug Sales Price Trend (2012-2017)
8.2 Southeast Asia Parkinson's Disease Drug Sales Volume and Market Share by Type
8.3 Southeast Asia Parkinson's Disease Drug Sales Volume and Market Share by Application

9 AUSTRALIA PARKINSON'S DISEASE DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Parkinson's Disease Drug Sales and Value (2012-2017)
  9.1.1 Australia Parkinson's Disease Drug Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Parkinson's Disease Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Parkinson's Disease Drug Sales Price Trend (2012-2017)
9.2 Australia Parkinson's Disease Drug Sales Volume and Market Share by Type
9.3 Australia Parkinson's Disease Drug Sales Volume and Market Share by Application

10 ASIA-PACIFIC PARKINSON'S DISEASE DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Merck
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Parkinson's Disease Drug Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Merck Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Akorn
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Parkinson's Disease Drug Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Akorn Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 GSK
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Parkinson's Disease Drug Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 GSK Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Novartis
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Parkinson's Disease Drug Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Novartis Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Boehringer Ingelheim
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Parkinson's Disease Drug Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Boehringer Ingelheim Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Teva Pharmaceutical
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Parkinson's Disease Drug Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Teva Pharmaceutical Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Abbvie
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Parkinson's Disease Drug Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Abbvie Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 Kyowa Hakko Kirin Pharma
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Parkinson's Disease Drug Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Astellas Pharma
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Parkinson's Disease Drug Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Astellas Pharma Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Desitin Arzneimittel
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Parkinson's Disease Drug Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Desitin Arzneimittel Parkinson's Disease Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Endo Pharmaceuticals
10.12 F.Hoffmann-La Roche
10.13 H.Lundbeck
10.14 Valeant
10.15 Apokyn
10.16 Orion
10.17 Stada Arzneimittel
10.18 US WorldMeds
10.19 Valeant Pharmaceuticals

11 PARKINSON'S DISEASE DRUG MANUFACTURING COST ANALYSIS

11.1 Parkinson's Disease Drug Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Parkinson's Disease Drug

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Parkinson's Disease Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC PARKINSON'S DISEASE DRUG MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Parkinson's Disease Drug Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Parkinson's Disease Drug Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Parkinson's Disease Drug Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Parkinson's Disease Drug Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Parkinson's Disease Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Parkinson's Disease Drug Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Parkinson's Disease Drug Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Parkinson's Disease Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Parkinson's Disease Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Parkinson's Disease Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Parkinson's Disease Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Parkinson's Disease Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Parkinson's Disease Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Parkinson's Disease Drug Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Parkinson's Disease Drug Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Parkinson's Disease Drug Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Parkinson's Disease Drug Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Parkinson's Disease Drug Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Parkinson's Disease Drug Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Parkinson's Disease Drug
Figure Asia-Pacific Parkinson's Disease Drug Sales Volume (K Units) by Type (2012-2022)
Figure Asia-Pacific Parkinson's Disease Drug Sales Volume Market Share by Type (Product Category) in 2016
Figure Sinemet-CR Product Picture
Figure Trastal Product Picture
Figure Madopar Product Picture
Figure COMT Inhibitor Product Picture
Figure Other Product Picture
Figure Asia-Pacific Parkinson's Disease Drug Sales (K Units) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Parkinson's Disease Drug by Application in 2016
Figure Under 40 Years Old Examples
Table Key Downstream Customer in Under 40 Years Old
Figure 40-65 Years Old Examples
Table Key Downstream Customer in 40-65 Years Old
Figure Above 65 Years Old Examples
Table Key Downstream Customer in Above 65 Years Old
Figure Asia-Pacific Parkinson's Disease Drug Market Size (Million USD) by Region (2012-2022)
Figure China Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Parkinson's Disease Drug Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Asia-Pacific Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Parkinson's Disease Drug Market Major Players Product Sales Volume (K Units)(2012-2017)
Table Asia-Pacific Parkinson's Disease Drug Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Parkinson's Disease Drug Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Parkinson's Disease Drug Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Parkinson's Disease Drug Sales Share by Players/Suppliers
Figure Asia-Pacific Parkinson's Disease Drug Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Parkinson's Disease Drug Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Parkinson's Disease Drug Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Parkinson's Disease Drug Revenue Share by Players
Figure 2017 Asia-Pacific Parkinson's Disease Drug Revenue Share by Players
Table Asia-Pacific Parkinson's Disease Drug Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Parkinson's Disease Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Parkinson's Disease Drug by Type (2012-2017)
Figure Asia-Pacific Parkinson's Disease Drug Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Parkinson's Disease Drug Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Parkinson's Disease Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Drug by Type (2012-2017)
Figure Asia-Pacific Parkinson's Disease Drug Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Parkinson's Disease Drug Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Asia-Pacific Parkinson's Disease Drug Sales Share by Region (2012-2017)
Figure Sales Market Share of Parkinson's Disease Drug by Region (2012-2017)
Figure Asia-Pacific Parkinson's Disease Drug Sales Market Share by Region in 2016
Table Asia-Pacific Parkinson's Disease Drug Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Parkinson's Disease Drug Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Drug by Region (2012-2017)
Figure Asia-Pacific Parkinson's Disease Drug Revenue Market Share by Region in 2016
Table Asia-Pacific Parkinson's Disease Drug Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Asia-Pacific Parkinson's Disease Drug Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Parkinson's Disease Drug Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Parkinson's Disease Drug Sales Market Share by Application (2012-2017)
Figure China Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure China Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Parkinson's Disease Drug Sales Price (USD/Unit) Trend (2012-2017)
Table China Parkinson's Disease Drug Sales Volume (K Units) by Type (2012-2017)
Table China Parkinson's Disease Drug Sales Volume Market Share by Type (2012-2017)
Figure China Parkinson's Disease Drug Sales Volume Market Share by Type in 2016
Table China Parkinson's Disease Drug Sales Volume (K Units) by Applications (2012-2017)
Table China Parkinson's Disease Drug Sales Volume Market Share by Application (2012-2017)
Figure China Parkinson's Disease Drug Sales Volume Market Share by Application in 2016
Figure Japan Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Parkinson's Disease Drug Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Parkinson's Disease Drug Sales Volume (K Units) by Type (2012-2017)
Table Japan Parkinson's Disease Drug Sales Volume Market Share by Type (2012-2017)
Figure Japan Parkinson's Disease Drug Sales Volume Market Share by Type in 2016
Table Japan Parkinson's Disease Drug Sales Volume (K Units) by Applications (2012-2017)
Table Japan Parkinson's Disease Drug Sales Volume Market Share by Application (2012-2017)
Figure Japan Parkinson's Disease Drug Sales Volume Market Share by Application in 2016
Figure South Korea Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure South Korea Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Parkinson's Disease Drug Sales Price (USD/Unit) Trend (2012-2017)
Table South Korea Parkinson's Disease Drug Sales Volume (K Units) by Type (2012-2017)
Table South Korea Parkinson's Disease Drug Sales Volume Market Share by Type (2012-2017)
Figure South Korea Parkinson's Disease Drug Sales Volume Market Share by Type in 2016
Table South Korea Parkinson's Disease Drug Sales Volume (K Units) by Applications (2012-2017)
Table South Korea Parkinson's Disease Drug Sales Volume Market Share by Application (2012-2017)
Figure South Korea Parkinson's Disease Drug Sales Volume Market Share by Application in 2016
Figure Taiwan Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Taiwan Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Parkinson's Disease Drug Sales Price (USD/Unit) Trend (2012-2017)
Table Taiwan Parkinson's Disease Drug Sales Volume (K Units) by Type (2012-2017)
Table Taiwan Parkinson's Disease Drug Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Parkinson's Disease Drug Sales Volume Market Share by Type in 2016
Table Taiwan Parkinson's Disease Drug Sales Volume (K Units) by Applications (2012-2017)
Table Taiwan Parkinson's Disease Drug Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Parkinson's Disease Drug Sales Volume Market Share by Application in 2016
Figure India Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure India Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Parkinson's Disease Drug Sales Price (USD/Unit) Trend (2012-2017)
Table India Parkinson's Disease Drug Sales Volume (K Units) by Type (2012-2017)
Table India Parkinson's Disease Drug Sales Volume Market Share by Type (2012-2017)
Figure India Parkinson's Disease Drug Sales Volume Market Share by Type in 2016
Table India Parkinson's Disease Drug Sales Volume (K Units) by Application (2012-2017)
Table India Parkinson's Disease Drug Sales Volume Market Share by Application (2012-2017)
Figure India Parkinson's Disease Drug Sales Volume Market Share by Application in 2016
Figure Southeast Asia Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Parkinson's Disease Drug Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Parkinson's Disease Drug Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Parkinson's Disease Drug Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Parkinson's Disease Drug Sales Volume Market Share by Type in 2016
Table Southeast Asia Parkinson's Disease Drug Sales Volume (K Units) by Applications (2012-2017)
Table Southeast Asia Parkinson's Disease Drug Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Parkinson's Disease Drug Sales Volume Market Share by Application in 2016
Figure Australia Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Australia Parkinson's Disease Drug Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Parkinson's Disease Drug Sales Price (USD/Unit) Trend (2012-2017)
Table Australia Parkinson's Disease Drug Sales Volume (K Units) by Type (2012-2017)
Table Australia Parkinson's Disease Drug Sales Volume Market Share by Type (2012-2017)
Figure Australia Parkinson's Disease Drug Sales Volume Market Share by Type in 2016
Table Australia Parkinson's Disease Drug Sales Volume (K Units) by Applications (2012-2017)
Table Australia Parkinson's Disease Drug Sales Volume Market Share by Application (2012-2017)
Figure Australia Parkinson's Disease Drug Sales Volume Market Share by Application in 2016
Table Merck Parkinson's Disease Drug Basic Information List
Table Merck Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Merck Parkinson's Disease Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck Parkinson's Disease Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Akorn Parkinson's Disease Drug Basic Information List
Table Akorn Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Akorn Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Akorn Parkinson's Disease Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Akorn Parkinson's Disease Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table GSK Parkinson's Disease Drug Basic Information List
Table GSK Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GSK Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure GSK Parkinson's Disease Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure GSK Parkinson's Disease Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis Parkinson's Disease Drug Basic Information List
Table Novartis Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Parkinson's Disease Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis Parkinson's Disease Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Boehringer Ingelheim Parkinson's Disease Drug Basic Information List
Table Boehringer Ingelheim Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Boehringer Ingelheim Parkinson's Disease Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Teva Pharmaceutical Parkinson's Disease Drug Basic Information List
Table Teva Pharmaceutical Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Teva Pharmaceutical Parkinson's Disease Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Abbvie Parkinson's Disease Drug Basic Information List
Table Abbvie Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbvie Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Abbvie Parkinson's Disease Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Abbvie Parkinson's Disease Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Basic Information List
Table Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Kyowa Hakko Kirin Pharma Parkinson's Disease Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Astellas Pharma Parkinson's Disease Drug Basic Information List
Table Astellas Pharma Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Astellas Pharma Parkinson's Disease Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Desitin Arzneimittel Parkinson's Disease Drug Basic Information List
Table Desitin Arzneimittel Parkinson's Disease Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Sales (K Units) and Growth Rate (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Sales Market Share in Asia-Pacific (2012-2017)
Figure Desitin Arzneimittel Parkinson's Disease Drug Revenue Market Share in Asia-Pacific (2012-2017)
Table Endo Pharmaceuticals Parkinson's Disease Drug Basic Information List
Table F.Hoffmann-La Roche Parkinson's Disease Drug Basic Information List
Table H.Lundbeck Parkinson's Disease Drug Basic Information List
Table Valeant Parkinson's Disease Drug Basic Information List
Table Apokyn Parkinson's Disease Drug Basic Information List
Table Orion Parkinson's Disease Drug Basic Information List
Table Stada Arzneimittel Parkinson's Disease Drug Basic Information List
Table US WorldMeds Parkinson's Disease Drug Basic Information List
Table Valeant Pharmaceuticals Parkinson's Disease Drug Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson's Disease Drug
Figure Manufacturing Process Analysis of Parkinson's Disease Drug
Figure Parkinson's Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2016
Table Major Buyers of Parkinson's Disease Drug
Table Distributors/Traders List
Figure Asia-Pacific Parkinson's Disease Drug Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Parkinson's Disease Drug Price (USD/Unit) and Trend Forecast (2017-2022)
Table Asia-Pacific Parkinson's Disease Drug Sales Volume (K Units) Forecast by Region (2017-2022)
Figure Asia-Pacific Parkinson's Disease Drug Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Parkinson's Disease Drug Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Parkinson's Disease Drug Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Parkinson's Disease Drug Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Parkinson's Disease Drug Revenue Market Share Forecast by Region in 2022
Figure China Parkinson's Disease Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure China Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Parkinson's Disease Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Parkinson's Disease Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure South Korea Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Parkinson's Disease Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Taiwan Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Parkinson's Disease Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure India Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Parkinson's Disease Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Parkinson's Disease Drug Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure Australia Parkinson's Disease Drug Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Parkinson's Disease Drug Sales (K Units) Forecast by Type (2017-2022)
Figure Asia-Pacific Parkinson's Disease Drug Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Parkinson's Disease Drug Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Parkinson's Disease Drug Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Parkinson's Disease Drug Price (USD/Unit) Forecast by Type (2017-2022)
Table Asia-Pacific Parkinson's Disease Drug Sales (K Units) Forecast by Application (2017-2022)
Figure Asia-Pacific Parkinson's Disease Drug Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources